We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

49 hedge funds and large institutions have $11.1M invested in Microbot Medical in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,464% more call options, than puts

Call options by funds: $4.64M | Put options by funds: $181K

240% more capital invested

Capital invested by funds: $3.26M → $11.1M (+$7.8M)

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

14% more funds holding

Funds holding: 43 → 49 (+6)

5.85% more ownership

Funds ownership: 6.21% → 12.06% (+5.9%)

Holders
49
Holders Change
+6
Holders Change %
+13.95%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
14
Reduced
9
Closed
8
Calls
$4.64M
Puts
$181K
Net Calls
+$4.46M
Net Calls Change
+$3.62M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.13M
2
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
+$1.46M
3
Morgan Stanley
Morgan Stanley
New York
+$327K
4
BlackRock
BlackRock
New York
+$204K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$187K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$173K
2
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$63K
3
VF
Virtu Financial
New York
-$42K
4
TFS
Thoroughbred Financial Services
Tennessee
-$40K
5
TRCT
Tower Research Capital (TRC)
New York
-$34.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$14.8K +$12.9K +5,390 +1,130%
SS
27
SBI Securities
Japan
$14.4K -$431 -180 -3%
BL
28
BFSG LLC
California
$13.9K – – –
CIAM
29
Caitong International Asset Management
Hong Kong
$8.25K +$7.72K +3,228 +7,173%
Osaic Holdings
30
Osaic Holdings
Arizona
$8.07K +$4.79K +2,001 +166%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$5K -$2 -1 -0.1%
TRCT
32
Tower Research Capital (TRC)
New York
$4.02K -$34.9K -14,576 -90%
SPIA
33
Steward Partners Investment Advisory
New York
$3.28K – – –
AAS
34
Ameritas Advisory Services
Nebraska
$2.99K +$2.84K +1,186 New
EWA
35
EverSource Wealth Advisors
Alabama
$900 – – –
T
36
Transce3nd
Texas
$832 – – –
AF
37
Allworth Financial
California
$328 +$311 +130 New
Raymond James Financial
38
Raymond James Financial
Florida
$36 +$33 +14 New
GC
39
Garde Capital
Washington
$6 – – –
Fidelity Investments
40
Fidelity Investments
Massachusetts
$3 -$14 -6 -86%
Barclays
41
Barclays
United Kingdom
$3 -$12 -5 -83%
EPIMS
42
Evelyn Partners Investment Management Services
$3 – – –
FDCDDQ
43
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3 – – –
FS
44
Financially Speaking
Colorado
$3 – – –
Jones Financial Companies
45
Jones Financial Companies
Missouri
$3 – – –
HNB
46
Hilltop National Bank
Wyoming
$3 +$2 +1 New
LFG
47
Larson Financial Group
Missouri
$3 +$2 +1 New
WWM
48
Wolff Wiese Magana
California
$3 +$2 +1 New
Envestnet Asset Management
49
Envestnet Asset Management
Illinois
– -$63K -41,742 Closed
VF
50
Virtu Financial
New York
– -$42K -27,655 Closed
1
2
3

MBOT Hedge Fund Activity: Q2 2025 in Review

49 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2025, worth a combined $11.1M — up 240% from $3.26M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new MBOT positions and 8 closed out — a net gain of 6 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.13M. The largest seller was Susquehanna International Group, cutting an estimated $173K.

  • 49 institutional investors held Microbot Medical (MBOT) as of Q2 2025, up from 43 in Q1 2025.
  • Funds reported $11.1M of Microbot Medical stock for Q2 2025, up 240% quarter-over-quarter.
  • 14 funds opened new Microbot Medical positions in Q2 2025 and 8 closed out, a net change of +6 holders.
  • The largest Microbot Medical buyer in Q2 2025 was Vanguard Group, an estimated $3.13M added.
  • The largest Microbot Medical seller in Q2 2025 was Susquehanna International Group, an estimated $173K sold.

Based on aggregated 13F filings for Q2 2025.